FDA Approved: SANCUSO — Supplemental Application (Cumberland Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for SANCUSO (granisetron) from Cumberland Pharmaceuticals Inc., updating the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• SANCUSO (GRANISETRON)

Snippet

SUPPL AP for SANCUSO (GRANISETRON)